Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

Diagnose Alzheimer’s disease with isotopes

DAI

During the course of the PRISTINE proposal we have developed the first high precision high sensitivity stable isotope measurements for a variety of vital elements, including Zn, and Cu . With these technical advances we realized that we could monitor stable isotopic changes within organisms that open up a new way to study metal homeostasis as well...

Funding Programme
Start Date
End Date
Total Funding
€ 150 000
European Countries Involved

Discovery of new Frontal Temporal Dementia multimodal spectral markers in biofluids.

IR4FTD

The central aim of the project is to apply multimodal spectroscopy combined with machine learning to identify a fingerprint for Frontal Temporal Dementia (FTD) and Alzheimer’s disease (AD) in saliva and plasma. FTD is the second most common dementia and usually affects individuals younger than 60 years old. FTD is difficult to diagnose, since there...

Funding Programme
Start Date
End Date
Total Funding
€ 287 152
European Countries Involved

Disrupting the Migraine continuum of care for resource constrained settings

TARA

Chronic migraine is defined as a headache persistent for more than 3 months or a severe headache persistent for more than 15 days within a month. It affects approximately 2% of the world population. The World Health Organization classifies severe migraine attacks as among the most disabling illnesses, comparable to dementia and quadriplegia...

Funding Programme
Start Date
End Date
Total Funding
€ 4 380 708
European Countries Involved

Dissecting Brain Pollutant Exposure and its Contribution to Neurodegeneration and Alzheimer’s disease: From Signatures to Prevention Strategies to Protect and Maintain a Healthy Brain

EXPOSIGNALZ

Human populations are impregnated by various types of chemical pollutants reported as hazardous waste present in the environment. Certain pollutants have adverse effects on brain, but the underlying mechanisms and time-window exposures are still unknown, as well as their contribution on dementia, the 7th leading cause of death. EXPOSIGNALZ project...

Funding Programme
Start Date
End Date
Total Funding
€ 930 987 982
European Countries Involved

Do T cells link loss and gain-of-function mechanism in C9orf72 ALS/FTD?

C9-T Immunity

Neurodegenerative diseases are the top 3 leading causes of death and are viewed now as systemic diseases. Adaptive immunity including a T-cell response in the central nervous system (CNS) likely contributes to disease pathogenesis. How T cells are primed and recruited to CNS is largely unexplored, due to the complexity of the process and lack of...

Funding Programme
Start Date
End Date
Total Funding
€ 1 498 610
European Countries Involved

Doctoral training network TAu imMunE: strategies for innovative diagnosis and therapies in dementia

TAME

There is an urgent medical need for efficient diagnostics for Alzheimer’s disease and related tauopathies, as well as disease modifying treatments, due to the heavy burden of the disease on patients, families and society. To address this public health issue, TAME R&I training network gathers leading academic and industrial experts in tau research...

Funding Programme
Start Date
End Date
Total Funding
€ 2 431 389
European Countries Involved

Drug DELIvery to the brain via CHOroid Plexus targeting

DeliChoP

CNS disorders, e.g. brain cancer and Alzheimers disease, are the most common, debilitating, and underserved diseases. CNS drugs have historically suffered from considerably lower success rates during development than those for non-CNS indications. One of the major reasons is the presence of CNS barriers, including the blood-brain (BBB) and blood...

Funding Programme
Start Date
End Date
Total Funding
€ 1 999 756
European Countries Involved

eBRAIN-Health - Actionable Multilevel Health Data

eBRAIN-Health

The Project eBrain-Health will deliver a distributed research platform for modeling and simulating complex neurobiological phenomena of human brain function and dysfunction in a data protection compliant environment. It will provide thousands of multilevel virtual brains from patients and healthy human controls for research and innovation. Brain...

Funding Programme
Start Date
End Date
Total Funding
€ 12 436 805

Elucidating and targeting the mechanisms encoded in the genome of long-lived individuals to improve healthy ageing

ElucidAge

Advancing age is the major risk factor for many serious illnesses, including cancer, cardiovascular disease, and dementia. The rising number of older individuals is thus causing a major burden of ill health. However, individuals that reach an exceptional old age often seem to escape or delay age-related diseases, and part of this trait seems to be...

Funding Programme
Start Date
End Date
Total Funding
€ 1 500 000
European Countries Involved

Elucidating the Microscopic Origins of the Light-Induced Gating Mechanism in Channelrhodopsin-2

ENLIGHT

Alzheimer's disease is the most common form of dementia. It affects millions of people and is expected to increase in the coming decades due to aging of the population. Optogenetics combines optics and genetics to gain insight into brain function by genetically inserting light-sensitive transmembrane proteins into neurons. Channelrhodopsin-2 (ChR2)...

Funding Programme
Start Date
End Date
Total Funding
€ 236 340
European Countries Involved

Enteric Bioelectronics for Sensing and Stimulating the CNS

EnterBio

Therapies for neurological disorders often involve deeply invasive brain operations or implants. A largely overlooked aspect of these conditions is the high comorbidity of GI-related disorders. Although the top-down relationship between the brain and peripheral organs has dominated the field, its now clear that activity of peripheral organs, in...

Funding Programme
Start Date
End Date
Total Funding
€ 2 634 485
European Countries Involved

Establishing Target Engagement and Selectivity for CTP Inhibitors in Cells: Synthesis and Application of CHOLesterol Probes for a Comprehensive MAPping of the Cholesterol Interactome

CholMap

Cholesterol is a structural component of membranes and plays a key role in human health by regulating the fluidity of membranes and affecting signaling pathways. Intracellular cholesterol transport proteins (CTP) are responsible for maintaining cholesterol homeostasis by regulating local cholesterol concentrations, arising from de novo biosynthesis...

Funding Programme
Start Date
End Date
Total Funding
€ 247 553
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).